Streetbeat News

Stock Prices

AAPL

Chinese online retailers have started offering discounts on the iPhone 16 ahead of its official release, indicating a potential cooling in demand due to AI-related delays. This could impact Apple's pricing strategy and sales in China.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 1:14 pm

RENB

RenovaroCube's AI platform, evaluated by PersonalAIze, shows promise in early cancer detection. The assessment was led by AI experts Mark Hoogendoorn and Sandjai Bhulai, highlighting the platform's potential in healthcare applications.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 1:12 pm

DELL

DH

INOD

JAKK

LSPD

Top Wall Street analysts initiated coverage on several companies, including Dell Technologies, Lightspeed Commerce, JAKKS Pacific, Definitive Healthcare, and Innodata. Dell received an Outperform rating with a $135 price target, while Lightspeed, JAKKS Pacific, and Definitive Healthcare received Buy ratings. Innodata also received a Buy rating but saw a share price decline.

Portfolio Pulse from Avi Kapoor

September 17, 2024 | 1:10 pm

CAPR

Capricor Therapeutics has entered a commercialization and distribution agreement with Nippon Shinyaku for its lead asset, deramiocel, in Europe. The deal includes a $20 million upfront payment, potential milestone payments up to $715 million, and a $15 million equity investment by Nippon Shinyaku. Capricor's stock rose 6.55% premarket.

Portfolio Pulse from Vandana Singh

September 17, 2024 | 1:07 pm

AIPI

GUNZ

PLTR

Palantir Technologies Inc. (NYSE:PLTR) has signed a multi-year, multi-million-dollar contract with Nebraska Medicine to enhance healthcare using its AI Platform. This partnership aims to improve patient care and operational efficiency. Palantir shares rose 2.2% premarket following the announcement.

Portfolio Pulse from Lekha Gupta

September 17, 2024 | 1:06 pm

CAPR

Capricor Therapeutics has announced an upfront payment and investment that extends its cash runway into 2026, providing financial stability and potential for growth.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 1:05 pm

SKYH

Sky Harbour Group shares are trading lower following the announcement of a securities purchase agreement, which will generate net proceeds of $31.8 million and an additional $63 million by December 2024.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 1:03 pm

ATHA

Athira Pharma is focusing on advancing ATH-1105 for neurodegenerative diseases, including ALS and AD, while reducing its workforce by 70% to save costs. The company expects one-time costs of $2.8M and annual savings of $13.4M, extending its cash runway into Q1 2026.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 1:02 pm

BOOM

DMC Global shares rise as Steel Connect reiterates its acquisition proposal at $16.50 per share.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 1:01 pm

AMLX

RPHM

XCUR

Insider buying activity has been observed in three penny stocks: Exicure, Amylyx Pharmaceuticals, and Reneo Pharmaceuticals. This insider activity may indicate confidence in the companies' prospects.

Portfolio Pulse from Avi Kapoor

September 17, 2024 | 1:01 pm